Case Report
A Platelet Acquired Storage Pool Disorder Associated with Tamoxifen Therapy
Table 1
Platelet aggregation and activation assays.
| | 12/08 | 3/09 | Normal |
| Platelet aggregation |
| ADP | | | | Percentage of aggregation | 78 | 61 | 70–100% max | ATP release | 0.85
| 0.23
| 0.2–1.6 nM
| AA | | | | Percentage of aggregation | 76 | 71 | 66–100% max | ATP release | 0.68
| 0.29
| 0–1.3 nM
| Collagen | | | | Percentage of aggregation | 87 | 74 | 70–100% max | ATP release | 1.02
| 0.53
| 0.4–1.9 nM
| Epinephrine | | | | Percentage of aggregation | 80 | 66 | 67–95% max | ATP release | 1.02 | 0.54 | 0.3–1.7 nM |
| Platelet activation |
| Percentage of mepacrine uptake | 33 | 63 | 54–84% | Percentage of mepacrine release
| 82 | 79 | 58–93% |
|
|
ADP: adenosine diphosphate; AA: arachidonic acid.
|